Report Detail
Global Sustained Release Injectables Market Opportunities and Forecast 2022-2028
- RnM4417967 |
- 04 April, 2022 |
- Global |
- 162 Pages |
- GRD Survey |
- Medical Devices & Consumables
This report provides a comprehensive analysis of current global Sustained Release Injectables market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Sustained Release Injectables industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.
According to GRD Survey, the global Sustained Release Injectables market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.
Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Sustained Release Injectables Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Sustained Release Injectables market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.
The Global Sustained Release Injectables Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Sustained Release Injectables industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions
Segmented by Type
Naltrexone
Exenatide
Segmented by Application
Diabetes
Leukemia
Acromegaly
Other
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Roche
Novartis
Eli Lilly
Critical Pharmaceuticals
Camurus
Biomarin
Avadel
Aurobindo
AstraZeneca
Ascendis Pharma
Amylin
Alkermes
Table of Contents
1 Product Introduction and Overview
- 1.1 Product Definition
- 1.2 Product Specification
- 1.3 Global Market Overview
- 1.3.1 Global Sustained Release Injectables Market Status and Forecast (2017-2028)
- 1.3.2 Global Sustained Release Injectables Sales Value CAGR by Region
- 1.4 Market Drivers, Inhibitors
- 1.4.1 Market Drivers
- 1.4.2 Market Inhibitors
- 1.4.3 COVID-19 Impact Analysis
2 Global Sustained Release Injectables Supply by Company
- 2.1 Global Sustained Release Injectables Sales Volume by Company
- 2.2 Global Sustained Release Injectables Sales Value by Company
- 2.3 Global Sustained Release Injectables Price by Company
- 2.4 Sustained Release Injectables Production Location and Sales Area of Main Manufacturers
- 2.5 Trend of Concentration Rate
3 Global and Regional Sustained Release Injectables Market Status by Type
- 3.1 Sustained Release Injectables Type Introduction
- 3.1.1 Naltrexone
- 3.1.2 Exenatide
- 3.1.3 Estradiol
- 3.1.4 Other
- 3.2 Global Sustained Release Injectables Market by Type
- 3.2.1 Global Sustained Release Injectables Sales Volume by Type (2017-2022)
- 3.2.2 Global Sustained Release Injectables Sales Value by Type (2017-2022)
- 3.2.3 Global Sustained Release Injectables Price by Type (2017-2022)
- 3.3 North America: by Type
- 3.4 Europe: by Type
- 3.5 Asia Pacific: by Type
- 3.6 Central & South America: by Type
- 3.7 Middle East & Africa: by Type
4 Global and Regional Sustained Release Injectables Market Status by Application
- 4.1 Sustained Release Injectables Segment by Application
- 4.1.1 Diabetes
- 4.1.2 Leukemia
- 4.1.3 Acromegaly
- 4.1.4 Other
- 4.2 Global Sustained Release Injectables Market by Application
- 4.2.1 Global Sustained Release Injectables Sales Volume by Application (2017-2022)
- 4.2.2 Global Sustained Release Injectables Sales Value by Application (2017-2022)
- 4.2.3 Global Sustained Release Injectables Price by Application (2017-2022)
- 4.3 North America: by Application
- 4.4 Europe: by Application
- 4.5 Asia Pacific: by Application
- 4.6 Central & South America: by Application
- 4.7 Middle East & Africa: by Application
5 Global Sustained Release Injectables Market Status by Region
- 5.1 Global Sustained Release Injectables Market by Region
- 5.1.1 Global Sustained Release Injectables Sales Volume by Region
- 5.1.2 Global Sustained Release Injectables Sales Value by Region
- 5.2 North America Sustained Release Injectables Market Status
- 5.3 Europe Sustained Release Injectables Market Status
- 5.4 Asia Pacific Sustained Release Injectables Market Status
- 5.5 Central & South America Sustained Release Injectables Market Status
- 5.6 Middle East & Africa Sustained Release Injectables Market Status
6 North America Sustained Release Injectables Market Status
- 6.1 North America Sustained Release Injectables Market by Country
- 6.1.1 North America Sustained Release Injectables Sales Volume by Country (2017-2022)
- 6.1.2 North America Sustained Release Injectables Sales Value by Country (2017-2022)
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 Europe Sustained Release Injectables Market Status
- 7.1 Europe Sustained Release Injectables Market by Country
- 7.1.1 Europe Sustained Release Injectables Sales Volume by Country (2017-2022)
- 7.1.2 Europe Sustained Release Injectables Sales Value by Country (2017-2022)
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Spain
8 Asia Pacific Sustained Release Injectables Market Status
- 8.1 Asia Pacific Sustained Release Injectables Market by Country
- 8.1.1 Asia Pacific Sustained Release Injectables Sales Volume by Country (2017-2022)
- 8.1.2 Asia Pacific Sustained Release Injectables Sales Value by Country (2017-2022)
- 8.2 China
- 8.3 Japan
- 8.4 Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australasia
9 Central & South America Sustained Release Injectables Market Status
- 9.1 Central & South America Sustained Release Injectables Market by Country
- 9.1.1 Central & South America Sustained Release Injectables Sales Volume by Country (2017-2022)
- 9.1.2 Central & South America Sustained Release Injectables Sales Value by Country (2017-2022)
- 9.2 Brazil
- 9.3 Argentina
- 9.4 Colombia
10 Middle East & Africa Sustained Release Injectables Market Status
- 10.1 Middle East & Africa Sustained Release Injectables Market by Country
- 10.1.1 Middle East & Africa Sustained Release Injectables Sales Volume by Country (2017-2022)
- 10.1.2 Middle East & Africa Sustained Release Injectables Sales Value by Country (2017-2022)
- 10.2 Iran
- 10.3 Israel
- 10.4 Turkey
- 10.5 South Africa
- 10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
- 11.1 Supply Chain Analysis
- 11.2 Production Process Chart Analysis
- 11.3 Raw Materials and Key Suppliers Analysis
- 11.3.1 Raw Materials Introduction
- 11.3.2 Raw Materials Key Suppliers List
- 11.4 Sustained Release Injectables Manufacturing Cost Analysis
- 11.5 Sustained Release Injectables Sales Channel and Distributors Analysis
- 11.5.1 Sustained Release Injectables Sales Channel
- 11.5.2 Sustained Release Injectables Distributors
- 11.6 Sustained Release Injectables Downstream Major Buyers
12 Global Sustained Release Injectables Market Forecast by Type and by Application
- 12.1 Global Sustained Release Injectables Sales Volume and Sales Value Forecast (2023-2028)
- 12.2 Global Sustained Release Injectables Forecast by Type
- 12.2.1 Global Sustained Release Injectables Sales Volume Forecast by Type
- 12.2.2 Global Sustained Release Injectables Sales Value Forecast by Type
- 12.2.3 Global Sustained Release Injectables Price Forecast by Type
- 12.3 Global Sustained Release Injectables Forecast by Application
- 12.3.1 Global Sustained Release Injectables Sales Volume Forecast by Application
- 12.3.2 Global Sustained Release Injectables Sales Value Forecast by Application
- 12.3.3 Global Sustained Release Injectables Price Forecast by Application
13 Global Sustained Release Injectables Market Forecast by Region/Country
- 13.1 Global Sustained Release Injectables Market Forecast by Region (2023-2028)
- 13.1.1 Global Sustained Release Injectables Sales Volume Forecast by Region (2023-2028)
- 13.1.2 Global Sustained Release Injectables Sales Value Forecast by Region (2023-2028)
- 13.2 North America Market Forecast
- 13.3 Europe Market Forecast
- 13.4 Asia Pacific Market Forecast
- 13.5 Central & South America Market Forecast
- 13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
- 14.1 Taiwan Liposome Company
- 14.1.1 Company Information
- 14.1.2 Sustained Release Injectables Product Introduction
- 14.1.3 Taiwan Liposome Company Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.1.4 SWOT Analysis
- 14.2 Sanofi
- 14.2.1 Company Information
- 14.2.2 Sustained Release Injectables Product Introduction
- 14.2.3 Sanofi Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.2.4 SWOT Analysis
- 14.3 Roche
- 14.3.1 Company Information
- 14.3.2 Sustained Release Injectables Product Introduction
- 14.3.3 Roche Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.3.4 SWOT Analysis
- 14.4 Novartis
- 14.4.1 Company Information
- 14.4.2 Sustained Release Injectables Product Introduction
- 14.4.3 Novartis Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.4.4 SWOT Analysis
- 14.5 Eli Lilly
- 14.5.1 Company Information
- 14.5.2 Sustained Release Injectables Product Introduction
- 14.5.3 Eli Lilly Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.5.4 SWOT Analysis
- 14.6 Critical Pharmaceuticals
- 14.6.1 Company Information
- 14.6.2 Sustained Release Injectables Product Introduction
- 14.6.3 Critical Pharmaceuticals Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.6.4 SWOT Analysis
- 14.7 Camurus
- 14.7.1 Company Information
- 14.7.2 Sustained Release Injectables Product Introduction
- 14.7.3 Camurus Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.7.4 SWOT Analysis
- 14.8 Biomarin
- 14.8.1 Company Information
- 14.8.2 Sustained Release Injectables Product Introduction
- 14.8.3 Biomarin Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.8.4 SWOT Analysis
- 14.9 Avadel
- 14.9.1 Company Information
- 14.9.2 Sustained Release Injectables Product Introduction
- 14.9.3 Avadel Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.9.4 SWOT Analysis
- 14.10 Aurobindo
- 14.10.1 Company Information
- 14.10.2 Sustained Release Injectables Product Introduction
- 14.10.3 Aurobindo Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.10.4 SWOT Analysis
- 14.11 AstraZeneca
- 14.12 Ascendis Pharma
- 14.13 Amylin
- 14.14 Alkermes
15 Conclusion
16 Methodology
Summary:
Get latest Market Research Reports on Sustained Release Injectables. Industry analysis & Market Report on Sustained Release Injectables is a syndicated market report, published as Global Sustained Release Injectables Market Opportunities and Forecast 2022-2028. It is complete Research Study and Industry Analysis of Sustained Release Injectables market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
